These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7511178)

  • 21. Simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocytes in gastrointestinal tissues of chronically SIV-infected rhesus monkeys.
    Schmitz JE; Veazey RS; Kuroda MJ; Levy DB; Seth A; Mansfield KG; Nickerson CE; Lifton MA; Alvarez X; Lackner AA; Letvin NL
    Blood; 2001 Dec; 98(13):3757-61. PubMed ID: 11739183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
    Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL
    J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques.
    Silvera P; Flanagan B; Kent K; Rud E; Powell C; Corcoran T; Bruck C; Thiriart C; Haigwood NL; Stott EJ
    AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1295-304. PubMed ID: 7848685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge.
    Yasutomi Y; Koenig S; Woods RM; Madsen J; Wassef NM; Alving CR; Klein HJ; Nolan TE; Boots LJ; Kessler JA
    J Virol; 1995 Apr; 69(4):2279-84. PubMed ID: 7884874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition.
    Wilson CC; Kalams SA; Wilkes BM; Ruhl DJ; Gao F; Hahn BH; Hanson IC; Luzuriaga K; Wolinsky S; Koup R; Buchbinder SP; Johnson RP; Walker BD
    J Virol; 1997 Feb; 71(2):1256-64. PubMed ID: 8995649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxic T lymphocytes specific for the synthetic VEINCTR peptide, a sequence found within the Fas molecule and env gp120 in the blood of HIV-1 seropositive individuals.
    Moukrim Z; Achour A
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):439-44. PubMed ID: 7580839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys.
    Burns DP; Collignon C; Desrosiers RC
    J Virol; 1993 Jul; 67(7):4104-13. PubMed ID: 8510218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of serum antibody reactivities to a conformational and to linear antigenic sites in the external envelope glycoprotein of simian immunodeficiency virus (SIVmac) induced by infection and vaccination.
    McBride BW; Corthals G; Rud E; Kent K; Webster S; Cook N; Cranage MP
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1033-41. PubMed ID: 7685372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope.
    Sharpe SA; Cope A; Dowall S; Berry N; Ham C; Heeney JL; Hopkins D; Easterbrook L; Dennis M; Almond N; Cranage M
    J Gen Virol; 2004 Sep; 85(Pt 9):2591-2602. PubMed ID: 15302953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simian immunodeficiency virus-specific cytotoxic T lymphocytes in rhesus monkeys: characterization and vaccine induction.
    Letvin NL; Miller MD; Shen L; Chen ZW; Yasutomi Y
    Semin Immunol; 1993 Jun; 5(3):215-23. PubMed ID: 8394161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.
    Koziel MJ; Dudley D; Afdhal N; Choo QL; Houghton M; Ralston R; Walker BD
    J Virol; 1993 Dec; 67(12):7522-32. PubMed ID: 7693974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
    Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.
    Robert-Guroff M; Aldrich K; Muldoon R; Stern TL; Bansal GP; Matthews TJ; Markham PD; Gallo RC; Franchini G
    J Virol; 1992 Jun; 66(6):3602-8. PubMed ID: 1374810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simian immunodeficiency virus-specific cytotoxic T lymphocytes are present in the AIDS-associated skin rash in rhesus monkeys.
    Yamamoto H; Ringler DJ; Miller MD; Yasutomi Y; Hasunuma T; Letvin NL
    J Immunol; 1992 Jul; 149(2):728-34. PubMed ID: 1624810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.
    Buge SL; Murty L; Arora K; Kalyanaraman VS; Markham PD; Richardson ES; Aldrich K; Patterson LJ; Miller CJ; Cheng SM; Robert-Guroff M
    J Virol; 1999 Sep; 73(9):7430-40. PubMed ID: 10438833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques.
    Kaur A; Daniel MD; Hempel D; Lee-Parritz D; Hirsch MS; Johnson RP
    J Virol; 1996 Nov; 70(11):7725-33. PubMed ID: 8892893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simian immunodeficiency virus nef peptide is a dominant cytotoxic T lymphocyte epitope in Indian-origin rhesus monkeys expressing the common MHC class I allele mamu-A*02.
    Newberg MH; Kuroda MJ; Charini WA; Miura A; Lord CI; Schmitz JE; Gorgone DA; Lifton MA; Kuus-Reichel K; Letvin NL
    Virology; 2002 Sep; 301(2):365-73. PubMed ID: 12359438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys.
    Yasutomi Y; Reimann KA; Lord CI; Miller MD; Letvin NL
    J Virol; 1993 Mar; 67(3):1707-11. PubMed ID: 8437240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
    Iseda S; Takahashi N; Poplimont H; Nomura T; Seki S; Nakane T; Nakamura M; Shi S; Ishii H; Furukawa S; Harada S; Naruse TK; Kimura A; Matano T; Yamamoto H
    J Virol; 2016 Jul; 90(14):6276-6290. PubMed ID: 27122584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.